SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹97 Cr | ₹72 Cr | ₹92 Cr | ₹74 Cr | ₹128 Cr |
What is the latest Total Non-Current Liabilities ratio of SUVEN PHARMACEUTICALS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹97 Cr |
Mar2023 | ₹72 Cr |
Mar2022 | ₹92 Cr |
Mar2021 | ₹74 Cr |
Mar2020 | ₹128 Cr |
How is Total Non-Current Liabilities of SUVEN PHARMACEUTICALS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹97 Cr | 34.45 | |
Mar2023 | ₹72 Cr | -22.06 | |
Mar2022 | ₹92 Cr | 24.63 | |
Mar2021 | ₹74 Cr | -42.11 | |
Mar2020 | ₹128 Cr | - |
Compare Total Non-Current Liabilities of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹28,771.1 Cr | 7.1% | 2.5% | 74.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,699.0 Cr | 0.6% | -4.6% | 20.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,584.0 Cr | 9.8% | 4.5% | 64.7% | Stock Analytics | |
CIPLA | ₹116,022.0 Cr | -2.9% | -3.9% | 1.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,463.0 Cr | 0.9% | -10.4% | 0.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,434.8 Cr | 0.9% | -0.3% | 27.9% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 7.1% |
2.5% |
74.1% |
SENSEX | 2% |
0.1% |
8.6% |
You may also like the below Video Courses